Family history of disease
Family history of disease has been studied in 1 paper since 2022: 1 observational study in people. The newest paper, Aug 25, 2022: “Utility of whole genome sequencing in assessing risk and clinically relevant outcomes for pulmonary fibrosis”.
1 paper studies it1 findingUpdated
See all 1 papers on family history of disease
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“a five-fold increase in those with a family history of disease versus those without (25% versus 5%)”
Humans: a single group. Cells, worms or flies and mice: nothing yet.
- 1 lab in 1 country
- Funders: AstraZeneca and others
- 1 of 1 finding with company ties
- Humans1
What did studies of family history of disease find?
1Studies of family history of disease measured one outcome, Rare qualifying variants.
Rare qualifying variants
upin humans1
1 study
Rare qualifying variants
upin humans1
Family history of disease is linked with higher rare qualifying variants in humans (five-fold (25% versus 5%)).
“a five-fold increase in those with a family history of disease versus those without (25% versus 5%)”
Humans
The European respiratory journal
Latest
The European Respiratory Journal
Utility of whole genome sequencing in assessing risk and clinically relevant outcomes for pulmonary fibrosis
Cohort study of 949 peopleIdiopathic pulmonary fibrosis